# The Association Between the Triglyceride–Glucose Index and the Risk of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study

**Authors:** Munther S. Momani, Raneem Dalaeen, Dia Sarhan, Zaid Sarhan, Suhib Awamleh, Yazan M. Momani, Omar Abu Farsakh

PMC · DOI: 10.3390/life16020345 · 2026-02-17

## TL;DR

This study finds that higher triglyceride–glucose index values are linked to increased risk of kidney disease in type 2 diabetes patients.

## Contribution

The study demonstrates that the TyG index is independently associated with diabetic kidney disease risk after adjusting for confounders.

## Key findings

- Patients with kidney disease had higher TyG index values compared to those without.
- The third and fourth TyG quartiles showed significantly increased odds of diabetic kidney disease.
- The TyG index had modest discriminative ability (AUC 0.57) and should be used with other tools.

## Abstract

This study aimed to evaluate the association between the triglyceride–glucose index (TyG) and the risk of diabetic kidney disease (DKD) in patients with type 2 diabetes mellitus. Methods: This study included 1347 patients with type 2 diabetes who attended the endocrinology clinic at Jordan University Hospital between May 2025 and October 2025. Medical records were reviewed to identify patients with documented DKD, and the TyG index was calculated for each patient. Results: Our results showed that patients with both late-stage kidney disease (mean 9.47 ± 0.74) and early-stage kidney disease (mean 9.42 ± 0.67) demonstrated elevated TyG index values compared to those without kidney disease (mean 9.27 ± 0.70). In the fully adjusted model, the association remained robust with an OR of 1.611 (95% CI: 1.330–1.951, p < 0.001), indicating that higher TyG index values are independently associated with increased kidney risk even after controlling for major confounding variables. When comparing TyG index quartiles, the second quartile showed no significant difference from the reference group, while the third quartile showed 66% increased odds (OR = 1.66, 95% CI: 1.176–2.345, p = 0.004) and the fourth quartile demonstrated 117% increased odds (OR = 2.174, 95% CI: 1.512–3.125, p < 0.001). The association between the TyG index and DKD was more significant in patients younger than 60 years, and in women. In conclusion, the TGI was associated with increased risk of DKD; however, its discriminative ability was modest (AUC 0.57). This indicates that the TGI alone is insufficient as a predictive tool and should be interpreted alongside established screening tools. Prospective studies are needed to clarify its causal role in DKD development.

## Linked entities

- **Diseases:** diabetic kidney disease (MONDO:0005016), type 2 diabetes mellitus (MONDO:0005148)

## Full-text entities

- **Genes:** INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, AGT (angiotensinogen) [NCBI Gene 183] {aka ANHU, SERPINA8, hFLT1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** DM (MESH:D003920), nephron loss (MESH:D007683), renal function decline (MESH:D060825), CKD (MESH:D051436), metabolic syndrome (MESH:D024821), hyperglycemia (MESH:D006943), fibrosis (MESH:D005355), nephrosclerosis (MESH:D009400), inflammation (MESH:D007249), injury to (MESH:D014947), proteinuria (MESH:D011507), metabolic disorder (MESH:D008659), obesity (MESH:D009765), contrast (MESH:D005119), acute kidney injury (MESH:D058186), retinopathy (MESH:D058437), hypertrophy (MESH:D006984), ESRD (MESH:D007676), cardiovascular (MESH:D002318), IR (MESH:D007333), renal involvement (MESH:C565423), vascular injury (MESH:D057772), Albuminuria (MESH:D000419), diabetic complications (MESH:D048909), hypertension (MESH:D006973), glucose (MESH:D018149), DKD (MESH:D003928), neuropathy (MESH:D009422), Excess adiposity (MESH:D018205), cardiac and renal disease (MESH:D007674), T2DM (MESH:D003924), cardiac and renal (MESH:D006331)
- **Chemicals:** aldosterone (MESH:D000450), Triglyceride (MESH:D014280), vitamin D (MESH:D014807), phosphorus (MESH:D010758), Glu (MESH:D018698), nitric oxide (MESH:D009569), metformin (MESH:D008687), aspirin (MESH:D001241), carbohydrates (MESH:D002241), FPG (-), sodium (MESH:D012964), TG (MESH:D013866), calcium (MESH:D002118), magnesium (MESH:D008274), Glucose (MESH:D005947), creatinine (MESH:D003404), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941665/full.md

---
Source: https://tomesphere.com/paper/PMC12941665